Filed March 4, 2024

Serial No. 98432248

Examining Attorney null

Class Custom manufacture of products relating to biotechnology, namely, custom manufacture of biopharmaceuticals for use in cell and gene therapies; custom manufacture of gene and cell-based therapy products, namely, genetically engineered cells and tissues for cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of biopharmaceuticals used in cell and gene therapies, and biopharmaceutical preparations; biotechnology contract manufacturing services, namely, contract manufacturing in the field of pharmaceuticals and biopharmaceuticals for cell and gene therapy using biological organisms in the manufacturing process; contract manufacturing services of gene and cell-based therapy products, namely, biopharmaceuticals for cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of biopharmaceuticals for cell and gene therapies and biopharmaceutical products, namely, biopharmaceuticals for cell and gene therapies; contract manufacturing services of technology for biopharmaceutical products and gene and cell-based products, namely, custom manufacture of biopharmaceuticals for cell and gene therapies; contract manufacturing services of technology for viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations, namely, custom manufacture of pharmaceuticals and biopharmaceuticals for cell and gene therapies; 100; 103; 106; 100; 101

Case Type Service mark